MSP 2003
Alternative Names: MSP-2003Latest Information Update: 09 Jan 2024
At a glance
- Originator Mindset Pharma
- Developer Otsuka America Pharmaceutical
- Class Indoles; Neuropsychotherapeutics; Pyrrolidines; Small molecules
- Mechanism of Action Serotonin 5-HT2A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Mental disorders